<!DOCTYPE html>
<html>
  <head>
    <title>Multiple Sclerosis</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/neurology/">neurology</a></li>
      <li class="active">Multiple Sclerosis</li>
  </ol>

  <div class="page-header">
 
    <h1>Multiple Sclerosis</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Multiple Sclerosis</strong></a>
          <div class="toc">
<ul>
<li><a href="#epidemiology">epidemiology</a></li>
<li><a href="#patterns">Patterns</a><ul>
<li><a href="#relapsing-remitting-ms">Relapsing-remitting MS</a></li>
<li><a href="#secondary-progressive-ms">Secondary progressive MS</a></li>
<li><a href="#benign-ms">Benign MS</a></li>
<li><a href="#primary-progressive-ms">Primary progressive MS</a></li>
</ul>
</li>
<li><a href="#diagnosis">diagnosis</a></li>
<li><a href="#differential-diagnosis">Differential diagnosis</a></li>
<li><a href="#investigations">Investigations</a></li>
<li><a href="#treatment">Treatment</a></li>
<li><a href="#other-sympotms">Other sympotms</a></li>
<li><a href="#managing-disability">Managing disability</a></li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>most prevalent non-injury related cause of long-term neurological disability in younger adult</p>
<p>autoimmune disease</p>
<p>not directly fatal</p>
<p>life expectancy = 6-11yrs</p>
</blockquote>
<h3 id="epidemiology">epidemiology</h3>
<ul>
<li>
<p>onset 20-40years</p>
</li>
<li>
<p>2.5x females compared to males</p>
<ul>
<li>males more severely affected</li>
</ul>
</li>
<li>
<p>more common increasing distance from equator</p>
<ul>
<li>?vit d</li>
</ul>
</li>
<li>
<p>1/5 wil have affected relative</p>
</li>
<li>
<p>smoking and EBV exposure</p>
</li>
</ul>
<h3 id="patterns">Patterns</h3>
<ul>
<li>
<p>inflammatory demyelination</p>
<ul>
<li>
<p>white and grey matter of CNS</p>
</li>
<li>
<p>peripheral nervous system unaffected</p>
</li>
<li>
<p>loss of myelin and neuronal/axonal injury</p>
</li>
<li>
<p>over time remyelination can repiar some of this damage</p>
</li>
<li>
<p>Plaques formed from dense clusters</p>
</li>
</ul>
</li>
<li>
<p>location, frequncy and balance of injury vs. repair determines pattern and associated diability</p>
</li>
<li>
<p>unpredictable course and prognosis</p>
</li>
<li>
<p>Typically begins with sudden episode</p>
<ul>
<li>
<p>blurring one eye (optic neuritis)</p>
</li>
<li>
<p>double vision (diplopia)</p>
</li>
<li>
<p>unsteadiness</p>
</li>
<li>
<p>sensory impairment</p>
<ul>
<li>upwards from legs</li>
</ul>
</li>
<li>
<p>dysfunction in limbs</p>
</li>
</ul>
</li>
<li>
<p>increasing severity over days - weeks then gradual resolution - patiral/complete over several weeks</p>
</li>
<li>
<p>first episode = clnically isolated syndrome</p>
</li>
<li>
<p>if 2nd episode or subclinical changes on MRI -> relapsing-remitting MS</p>
</li>
</ul>
<h4 id="relapsing-remitting-ms">Relapsing-remitting MS</h4>
<ul>
<li>
<p>most common pattern (85%)</p>
</li>
<li>
<p>recurrent acute neruo episodes = relapses</p>
<ul>
<li>residual symptoms suddenly increase or new symptoms developing</li>
</ul>
</li>
<li>
<p>recovery gradual </p>
<ul>
<li>residual symptoms often remain</li>
</ul>
</li>
<li>
<p>1 relapse q2yrs</p>
<ul>
<li>frequency and severity vary widely</li>
</ul>
</li>
<li>
<p>high frequency during first 2 years</p>
<ul>
<li>linked to increase likelihood of people devleoping secondary progressive MS and long term disability</li>
</ul>
</li>
</ul>
<h4 id="secondary-progressive-ms">Secondary progressive MS</h4>
<ul>
<li>
<p>2/3 with R-R MS</p>
<ul>
<li>within 15yrs of diagnosis</li>
</ul>
</li>
<li>
<p>progressive worsening of neruological function</p>
<ul>
<li>
<p>independent of acute relapses</p>
<ul>
<li>
<p>low-grade degenerative process</p>
</li>
<li>
<p>long-term disability in peopel with MS</p>
</li>
</ul>
</li>
<li>
<p>acute attacks may still occur</p>
</li>
</ul>
</li>
</ul>
<h4 id="benign-ms">Benign MS</h4>
<ul>
<li>
<p>1/10</p>
</li>
<li>
<p>period of 10-20yrs without significant disability</p>
</li>
</ul>
<h4 id="primary-progressive-ms">Primary progressive MS</h4>
<ul>
<li>
<p>1/10 with MS</p>
</li>
<li>
<p>develop insidiously and progressively from outset</p>
</li>
</ul>
<h3 id="diagnosis">diagnosis</h3>
<blockquote>
<p>McDonald criteria:</p>
<p>2 or more episodes of inflammatory demyelination to cocur on seperate occasions at lease 30d apart in differnet locations</p>
<p>spearation in time and spacea can be estabilshed with single MRI</p>
</blockquote>
<ul>
<li>
<p>may report positive or negative symptoms</p>
</li>
<li>
<p>positive</p>
<ul>
<li>
<p>muscle spasm</p>
</li>
<li>
<p>1/5 will various forms of neuralgia</p>
<ul>
<li>tingling/burning/pruritic sensations in skin of limbs, trunk, face</li>
</ul>
</li>
<li>
<p>electric shock sensation down spine when neck is flexed (Lhermitte’s symptom)</p>
<ul>
<li>characteristic but not specific</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Negative</p>
<ul>
<li>
<p>visual disturbance</p>
<ul>
<li>
<p>decrease VA</p>
</li>
<li>
<p>diploplia</p>
</li>
</ul>
</li>
<li>
<p>numbness</p>
</li>
<li>
<p>motor dysfucntion</p>
<ul>
<li>
<p>weakness</p>
</li>
<li>
<p>gait disturbances</p>
</li>
<li>
<p>ataxia</p>
</li>
</ul>
</li>
<li>
<p>bladder dysfunction</p>
</li>
<li>
<p>bowel/erectile dysfuction</p>
</li>
</ul>
</li>
<li>
<p>may experience transient worsening of symptoms due to heat</p>
<ul>
<li>Uhthoff’s symptom</li>
</ul>
</li>
<li>
<p>optic neuritis</p>
<ul>
<li>
<p>1/4 of people with MS present with this</p>
</li>
<li>
<p>more prevalent among younger women</p>
</li>
<li>
<p>impairment of VA</p>
</li>
<li>
<p>reduced colour vision</p>
<ul>
<li>
<p>red desaturation</p>
</li>
<li>
<p>ishihara plates detect reduction in colour perception in 88%</p>
</li>
</ul>
</li>
<li>
<p>eye pain - especially on movement</p>
</li>
<li>
<p>swelling may be observed</p>
</li>
<li>
<p>RAPD present</p>
</li>
<li>
<p>after attck disc may appear pale</p>
<ul>
<li>optic atrophy</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Internuclear opthalmoplegia</p>
<ul>
<li>
<p>damage to neuronal connections</p>
</li>
<li>
<p>abducens (VI) and oculomotor (III) cranial nerve nuclei</p>
</li>
<li>
<p>affects horizontal gaze</p>
</li>
<li>
<p>when looks laterally to unaffected side</p>
<ul>
<li>
<p>impairment of adduction in affected eye</p>
</li>
<li>
<p>lags behind unaffected eye</p>
</li>
<li>
<p>‘adduction’ lag</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>extensor plantar response</p>
<ul>
<li>can be seen</li>
</ul>
</li>
</ul>
<h3 id="differential-diagnosis">Differential diagnosis</h3>
<ul>
<li>
<p>psychiatric </p>
</li>
<li>
<p>sciatica/msk injury</p>
</li>
<li>
<p>carpal tunnel syndrome nad other peripheral nerve disorders</p>
</li>
</ul>
<h3 id="investigations">Investigations</h3>
<ul>
<li>
<p>MRI = sensitivity of 95%</p>
<ul>
<li>
<p>history often underestimates disease severity</p>
</li>
<li>
<p>other asympomatic cns lesions will be detected on MRI \~80% of people</p>
</li>
</ul>
</li>
<li>
<p>Visual evoked potentioals</p>
<ul>
<li>
<p>subclincal demyelination of optic nerve</p>
</li>
<li>
<p>non specific and may be N in half MS</p>
</li>
</ul>
</li>
<li>
<p>Oligoclonal bands in CSF</p>
<ul>
<li>
<p>present 95% iwth well established MS</p>
</li>
<li>
<p>rarely required where characteristic history and MRI changes</p>
</li>
</ul>
</li>
</ul>
<h3 id="treatment">Treatment</h3>
<ul>
<li>
<p>3x disease modifing agents</p>
<ul>
<li>
<p>require SA from neurologist</p>
</li>
<li>
<p>complex actions on immune function and mechanism uncertain</p>
</li>
<li>
<p>similar, limited effects on course</p>
</li>
<li>
<p>1/3 reduction in frequnce of relapses</p>
</li>
<li>
<p>non appear effective with secondary progressive MS</p>
</li>
</ul>
</li>
<li>
<p><strong>Acute relapses managed with methylprednisolone</strong></p>
<ul>
<li>relapses more common who have viral infections or major life events</li>
</ul>
</li>
<li>
<p>influenza vaccination may reduce likelihood of MS relapses and minimise risk of respiratory complciations</p>
</li>
</ul>
<h3 id="other-sympotms">Other sympotms</h3>
<ul>
<li>
<p>Fatigue</p>
<ul>
<li>
<p>85% of those with MS</p>
</li>
<li>
<p>muscle weakenss and ataxia also present</p>
</li>
<li>
<p>consider</p>
<ul>
<li>
<p>depression</p>
</li>
<li>
<p>poor sleep</p>
</li>
<li>
<p>pain</p>
</li>
<li>
<p>inadequate nutrition</p>
</li>
</ul>
</li>
<li>
<p>exercise </p>
</li>
<li>
<p>pysiotherapy</p>
</li>
<li>
<p>aspirin and amantadine = some benefit</p>
</li>
</ul>
</li>
<li>
<p>pain affects 2/3</p>
<ul>
<li>
<p>restricted movmeent or muscle spasms</p>
</li>
<li>
<p>peripheral pain can be managed with analgesics and physiotherapy</p>
</li>
<li>
<p>CNS lesions also cause pain</p>
</li>
</ul>
</li>
<li>
<p>bowel dysufcntion</p>
<ul>
<li>
<p>constipation/faecal incontinence 60%</p>
</li>
<li>
<p>fuild/fibre increased before laxative considered</p>
</li>
<li>
<p>overflow incontinence</p>
</li>
<li>
<p>may have difficulty initiating bowel movmeent</p>
<ul>
<li>
<p>digital rotatoy stinulation</p>
</li>
<li>
<p>or suppositories</p>
<ul>
<li>bisacodyl or glycerl</li>
</ul>
</li>
</ul>
</li>
<li>
<p>loperamide = first line</p>
</li>
</ul>
</li>
<li>
<p>bladder dysfunction</p>
<ul>
<li>
<p>anticholinergics</p>
<ul>
<li>
<p>may cause incomplete bladder emptying</p>
</li>
<li>
<p>urinary self-catherisation</p>
</li>
</ul>
</li>
<li>
<p>nocturia</p>
<ul>
<li>
<p>desmopressin</p>
<ul>
<li>subsidised by neurologist</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Spasticity and spasm</p>
<ul>
<li>
<p>physiotherapy</p>
</li>
<li>
<p>cannabidiol plus tetrahydrocannabinol oromuscoal spray = adjunctive treatment for moderate to severe spasitiicyt</p>
<ul>
<li>
<p>not subs</p>
</li>
<li>
<p>erquires ministerial approval</p>
</li>
<li>
<p>contraindicated in severe psychiatric disorders/psychosis</p>
</li>
</ul>
</li>
<li>
<p>baclofen 5mg tds increase 3 day intervals - maintence = 30-80mg/day</p>
</li>
<li>
<p>orphenadrine 100mg bd</p>
</li>
<li>
<p>Dantrolene 25mg od increase to 25mg 2-4 times/day every 4-7 days</p>
</li>
<li>
<p>diazepam</p>
</li>
<li>
<p>Fampridine</p>
</li>
</ul>
</li>
</ul>
<p>19mg orally bd </p>
<h3 id="managing-disability">Managing disability</h3>
<ul>
<li>
<p>cognitive impairment</p>
<ul>
<li>1/2</li>
</ul>
</li>
<li></li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
